Fact Source: Financial Supervisory Service (DART) / 2026-07-16
Disclosure Type: Report on Major Matters / Decision on Bonus Issue
💡 3-Second Summary
Alteogen has resolved on a bonus issue allocating 0.3 new shares per 1 common and redeemable convertible preferred share, funded by capital surplus of approximately KRW 8.09 billion. The new share allotment baseline date is August 6, 2026, with the listing scheduled for August 20.
📊 1. [Summary of Core Disclosure Content and Major Figures]
- Type and Number of New Shares:
- Common Shares: 16,068,790 shares
- Other Shares (5th Series Registered Redeemable Convertible Preferred Shares): 122,037 shares
- Total New Shares: 16,190,827 shares
- Outstanding Shares Before Bonus Issue: 53,586,343 common shares / 406,793 other shares (Total 53,993,136 shares)
- Outstanding Shares After Bonus Issue (Including Treasury Shares):
- Common Shares: 69,655,133 shares (69,631,425 common shares excluding treasury shares + 23,708 treasury common shares)
- Redeemable Convertible Preferred Shares: 528,830 shares
- Total Outstanding: 70,183,963 shares
- Par Value per Share: KRW 500
- Allotment Conditions & Fractional Shares:
- New Shares per 1 Share: 0.3 shares for both common and other shares
- Treasury shares (23,708 common shares) are excluded from the allotment.
- Fractional shares of less than 1 share will be paid in cash based on the closing price of the new shares on the first day of listing.
- Key Timeline:
- New Share Allotment Baseline Date: August 06, 2026
- Scheduled Listing Date of New Shares: August 20, 2026
- Board Resolution Date: July 16, 2026 (All 4 outside directors attended, auditor attended)
- ※ The scheduled date for the delivery of new share certificates has been omitted as it is not applicable under the electronic securities system.
- Funding Source: Capital surplus in excess of par value of KRW 8,095,413,500
📈 2. [Expert Perspective: What This Disclosure Means for Investors]
- Capital Increase via Surplus Allotment: This filing officially registers the board’s decision to issue new common and preferred shares by utilizing KRW 8,095,413,500 of capital surplus in excess of par value as the funding source.
- Adjustment of Outstanding Shares: Under this resolution, 16,068,790 new common shares and 122,037 new preferred shares will be distributed to shareholders on record, excluding the 23,708 treasury shares. As a result, the total number of issued common shares will expand from 53,586,343 to 69,655,133.
- No Financial Performance Causes Specified: This filing reports the administrative decision to execute a bonus issue. It does not contain any explanations regarding historical financial fluctuations or concrete causes behind financial results.
📝 Editor’s Comment (by K-STOCK Editor)
Alteogen’s latest disclosure outlines its board’s decision to execute a bonus issue for common and redeemable convertible preferred shares at a ratio of 0.3 new shares per 1 existing share, utilizing KRW 8,095,413,500 of capital surplus in excess of par value. The allotment baseline date is scheduled for August 6, 2026, with the 23,708 treasury common shares excluded from the allocation of new shares.
For investors reviewing this announcement, the primary operational checkpoints are ‘the schedule for the new share allotment and the subsequent listing.’ As indicated in the filing, fractional shares representing less than one full share will be paid in cash based on the first day’s closing price, and the overall timeline remains subject to adjustments during consultations with relevant regulatory authorities. Consequently, investors should focus on verifying the progress of the stated allotment baseline date (August 6) and the listing date (August 20) through subsequent regulatory disclosures.
📢 Disclaimer & Source Information
Source: This content was restructured and newly drafted based on the official submitted data from the Financial Supervisory Service (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.
Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
